A new analysis of 16 studies suggests that robotic surgery for rectal cancer may offer some advantages over traditional laparoscopic surgery in younger patients. The review found that robotic low anterior resection was linked to fewer conversions to open surgery, lower overall complications, and a shorter hospital stay. It also showed higher rates of complete tumor removal and lower 30-day mortality and reoperation rates.
However, robotic surgery took about 25 minutes longer on average. The evidence quality ranged from very low to moderate, meaning the findings are not definitive. The analysis included both observational studies and randomized trials, so the results show associations, not proof of cause and effect.
Importantly, there were no significant differences in long-term outcomes like cancer recurrence or survival. The review could not pool data on functional outcomes such as bowel or sexual function, which are important for quality of life.
For younger patients with rectal cancer, robotic surgery may be a reasonable option, but more high-quality research is needed to confirm these potential benefits. Patients should discuss the risks and benefits of both approaches with their surgeon.